+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis



Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis



Value in Health 15(5): 716-723



To explore an alternative approach to quantifying the burden of side effects at 1 year after treatment for prostate cancer among both patients and their partners. We analyzed data from 75 couples in the Family and Cancer Therapy Selection study. Paired patients and family members were independently asked about their willingness to pay (WTP) for a hypothetical new treatment that cures prostate cancer without side effects if they could reconsider their treatment decision by indicating the maximum amount they would be willing to pay given 11 separate "bids" ranging from $0 to $1500 per month. Descriptive and regression analyses were conducted for patients and family members controlling for sociodemographic characteristics and health status; Spearman correlations were also examined. Among 75 couples analyzed, the income-adjusted mean WTP estimates per month were $400.8 (standard error [SE] $54.3) for patients and $650.2 (SE 72.2) for family members. The WTP between patients and family members was correlated (Pearson ρ 0.30; P = 0.01). After adjusting for covariates, the adjusted mean WTP per month was $588.1 (SE 65.77) for patients and $819.4 (SE 74.33) for family members. Wanting to avoid side effects at baseline predicted higher WTP for patients (P = 0.010). Experiencing sexual side effects was predictive of higher WTP for family members (P = 0.047). Fairly high WTP amounts for a hypothetical treatment without side effects suggests that patients and their partners are experiencing important burdens 1 year after treatment. The higher amounts partners are willing to pay and the correlation with sexual side effects suggest that they are perceptive of significant treatment burdens.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036446317

Download citation: RISBibTeXText

PMID: 22867781

DOI: 10.1016/j.jval.2012.03.003


Related references

Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients. Oncotarget 9(12): 10402-10416, 2018

Willingness of cancer patients to help family members to quit smoking. Psycho-Oncology 20(7): 724-729, 2011

Health-related quality of life in family members of patients with an advanced cancer diagnosis: a one-year prospective study. Health and Quality of Life Outcomes 10: 89, 2013

The willingness and actual situation of Chinese cancer patients and their family members participating in medical decision-making. Psycho-Oncology 24(12): 1663-1669, 2017

An e-learning caregiving program for prostate cancer patients and family members. Journal of Medical Systems 27(1): 1-12, 2003

Older patients' willingness to trade off urologic adverse outcomes for a better chance at five-year survival in the clinical setting of prostate cancer. Journal of the American Geriatrics Society 43(9): 979-984, 1995

p53 family members in cancer diagnosis and treatment. Seminars in Cancer Biology 20(1): 57-62, 2010

The experiences of family members in the year following the diagnosis of a child or adolescent with cancer: a qualitative systematic review. Jbi Database of Systematic Reviews and Implementation Reports 13(5): 293-329, 2016

Prostate cancer support and advocacy groups: their role for patients and family members. Seminars in Urologic Oncology 20(1): 45-54, 2002

Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines. International Journal of Molecular Medicine 28(1): 89-93, 2011

Determinants of Willingness to Become Organ Donors among Dialysis Patients' Family Members. Urology Journal 12(4): 2245-2250, 2016

A two year experience of support group for family members of cancer patients. European Journal of Cancer 35(SUPPL 4): S367, Sept, 1999

Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?. American Journal of Surgical Pathology 28(7): 946-952, 2004

Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. Journal of Clinical Oncology 15(4): 1478-1480, 1997

The Labor Productivity Effects Of Prostate Cancer Patients On Spouses And Other Family Members: Evidence From Us National Survey Data. Value in Health 16(3): A135-A136, 2013